LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 98 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37 | -51.9% | 33,876 | +1.0% | 0.00% | – |
| Q2 2023 | $77 | -6.1% | 33,526 | -0.3% | 0.00% | – |
| Q1 2023 | $82 | +28.1% | 33,626 | 0.0% | 0.00% | – |
| Q4 2022 | $64 | -99.9% | 33,626 | +0.3% | 0.00% | – |
| Q3 2022 | $80,000 | +29.0% | 33,539 | +0.6% | 0.00% | – |
| Q2 2022 | $62,000 | -11.4% | 33,342 | -0.5% | 0.00% | – |
| Q1 2022 | $70,000 | -47.0% | 33,499 | +0.2% | 0.00% | – |
| Q4 2021 | $132,000 | -18.5% | 33,447 | -0.4% | 0.00% | – |
| Q3 2021 | $162,000 | -39.8% | 33,596 | -42.6% | 0.00% | – |
| Q2 2021 | $269,000 | +57.3% | 58,522 | +100.4% | 0.00% | – |
| Q1 2021 | $171,000 | +71.0% | 29,200 | 0.0% | 0.00% | – |
| Q4 2020 | $100,000 | +138.1% | 29,200 | 0.0% | 0.00% | – |
| Q3 2020 | $42,000 | -27.6% | 29,200 | 0.0% | 0.00% | – |
| Q2 2020 | $58,000 | +1.8% | 29,200 | 0.0% | 0.00% | – |
| Q1 2020 | $57,000 | -52.9% | 29,200 | 0.0% | 0.00% | – |
| Q4 2019 | $121,000 | +37.5% | 29,200 | 0.0% | 0.00% | – |
| Q3 2019 | $88,000 | -52.2% | 29,200 | 0.0% | 0.00% | – |
| Q2 2019 | $184,000 | -26.7% | 29,200 | -35.3% | 0.00% | – |
| Q1 2019 | $251,000 | -23.0% | 45,100 | -8.2% | 0.00% | – |
| Q4 2018 | $326,000 | -37.8% | 49,148 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $524,000 | -11.2% | 49,148 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $590,000 | +40.1% | 49,148 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $421,000 | -42.8% | 49,148 | -34.0% | 0.00% | 0.0% |
| Q4 2017 | $736,000 | +7.6% | 74,478 | +33.7% | 0.00% | 0.0% |
| Q3 2017 | $684,000 | -25.3% | 55,689 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $916,000 | +2.7% | 55,689 | -10.5% | 0.00% | 0.0% |
| Q1 2017 | $892,000 | +3.6% | 62,236 | +0.0% | 0.00% | 0.0% |
| Q4 2016 | $861,000 | -23.5% | 62,235 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $1,125,000 | +50.6% | 62,235 | +19.5% | 0.00% | +100.0% |
| Q2 2016 | $747,000 | -21.5% | 52,085 | -34.5% | 0.00% | 0.0% |
| Q1 2016 | $951,000 | -59.7% | 79,556 | -55.1% | 0.00% | -75.0% |
| Q4 2015 | $2,358,000 | +321.8% | 177,168 | +240.2% | 0.00% | +300.0% |
| Q3 2015 | $559,000 | +32.5% | 52,085 | -0.7% | 0.00% | 0.0% |
| Q2 2015 | $422,000 | – | 52,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |